Q3 2024 Earnings Call Transcript November 6, 2024 Tandem Diabetes Care, Inc. beats earnings expectations. Reported EPS is $-0 ...

After multiple rejections, Lexicon Pharmaceuticals is inching toward an FDA decision date next month for its adjunct type 1 ...

MONTANA - Diabetes is a widespread issue throughout the United States, and Montana is no exception. According to the American ...

We are living in exciting times regarding therapies for people with diabetes. Much of the excitement ... precise regulatory guidance will still be needed for discussion and decision making about ...

Taking steps to prevent and manage diabetes by blood sugar monitoring ... rapidly and can enter advanced stages with little warning. Engaging patients in discussions about risk factors and symptoms ...

Lexicon Pharmaceuticals received a negative vote from a Food and Drug Administration advisory committee for Zynquista as an adjunct to insulin therapy for glycemic control in adults with Type 1 ...

Lexicon Pharmaceuticals shares have been halted all day as a Food and Drug Administration advisory committee was scheduled to vote on Zynquista as an adjunct to insulin therapy for glycemic control in ...

The event will feature expert local endocrinologists and healthcare professionals leading lectures and discussions on diabetes management and prevention. Attendees can participate in various health ...

The world once again will spend time talking about Diabetes on World Diabetes Day (November 14th). As we all encourage each other to get tested ...

Donald Trump's visible shift from his usual Diet Coke to regular Coke has sparked a discussion on health implications ...

Q3 2024 Earnings Conference Call November 8, 2024 8:30 AM ETCompany ParticipantsLauren Marek - LifeSci AdvisorsLaura Niklason ...